Vitamin D Reduces the Activity of Adenosine Deaminase and Oxidative Stress in Patients with Type Two Diabetes Mellitus
Molecular Nutrition & Food Research · 2024
DOI: 10.1002/mnfr.202300870 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Mahmoud A Alfaqih und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, 15503, Bahrain. Hauptthemen laut MEDLINE: Adenosine Deaminase, Oxidative Stress, Diabetes Mellitus, Type 2, Vitamin D. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deanship of Research at Jordan University of Science and Technology, College of Medicine and Health Sciences, UAE University (grant# G00004697, Fund# 12M176).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Scope Patients with Type 2 diabetes mellitus (T2DM) have lower levels of vitamin D. An elevation in uric acid (UA) contributes to T2DM via an increase in oxidative stress. Adenosine deaminase (ADA) is an enzyme of the purine degradation pathway. It is hypothesized that a reduction of ADA activity via vitamin D supplementation reduces UA and oxidative stress. Methods and results A total of 162 participants (81 with T2DM and 81 controls) are enrolled in a case–control study. A follow‐up interventional study is performed on 30 patients with vitamin D deficiency. These patients receive 50 000 IU (international units) of vitamin D3 on a weekly basis for 12 weeks. This intervention is followed by the measurement of several markers. T2DM patients has higher ADA activity, UA, and lipid peroxidation but lower 25‐hydroxy‐vitamin D (25 (OH) vitamin D) and GSH/GSSG ratio ( p < 0.05). Vitamin D supplementation results in a reduction of ADA activity and UA levels ( p < 0.05) along with an increase in GSH/GSSG ratio ( p < 0.05). Conclusion The results highlight the presence of an axis in T2DM patients between ADA, UA, and oxidative stress. Modulation of this axis can be achieved by clinically approved vitamin D supplementation protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, 15503, Bahrain.
- Department of Physiology and Biochemistry, Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.
- Department of Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, 15551, United Arab Emirates.
ORCID-Profile: Mahmoud A Alfaqih, Ebaa Ababneh, Mohammed Z Allouh
Förderung
- Deanship of Research at Jordan University of Science and Technology
- College of Medicine and Health Sciences, UAE University (grant# G00004697, Fund# 12M176)
Zitieren
APA
Alfaqih, M. A., Ababneh, E., Mhedat, K., & Allouh, M. Z. (2024). Vitamin D Reduces the Activity of Adenosine Deaminase and Oxidative Stress in Patients with Type Two Diabetes Mellitus. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300870
Vancouver
Alfaqih MA, Ababneh E, Mhedat K, Allouh MZ. Vitamin D Reduces the Activity of Adenosine Deaminase and Oxidative Stress in Patients with Type Two Diabetes Mellitus. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202300870
BibTeX
@article{Alfaqih2024,
author = {Alfaqih, Mahmoud A and Ababneh, Ebaa and Mhedat, Khawla and Allouh, Mohammed Z},
title = {Vitamin D Reduces the Activity of Adenosine Deaminase and Oxidative Stress in Patients with Type Two Diabetes Mellitus},
journal = {Molecular Nutrition & Food Research},
year = {2024},
doi = {10.1002/mnfr.202300870}
}
EUVIMED